Created in 2007 (United States), RILONACEPT own 16 sister brands and 2214 competing brands. The RILONACEPT brand is owned by Regeneron Pharmaceuticals, a company listed in New York. RILONACEPT is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
Regeneron Pharmaceuticals
(RILONACEPT)
over 5 years*
USD 2,313.30